6-substituted 2,3,4,5-tetrahydro-1H-benzo[D]azepines as 5-HT2C receptor agonists

摘要

Disclosed is a benzoazepine compound of formula I wherein the substituents are disclosed within the specification. Also disclosed is the use of a compound of formula I for the manufacture of a medicament for the treatment of obesity, an obsessive/compulsive disorder, depression or anxiety.